Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response
- PMID: 24131709
- PMCID: PMC3838294
- DOI: 10.1128/JVI.02666-13
Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response
Abstract
Chikungunya virus (CHIKV) is a reemerging mosquito-borne pathogen that causes incapacitating disease in humans characterized by intense joint pain that can persist for weeks, months, or even years. Although there is some evidence of persistent CHIKV infection in humans suffering from chronic rheumatologic disease symptoms, little is known about chronic disease pathogenesis, and no specific therapies exist for acute or chronic CHIKV disease. To investigate mechanisms of chronic CHIKV-induced disease, we utilized a mouse model and defined the duration of CHIKV infection in tissues and the associated histopathological changes. Although CHIKV RNA was readily detectable in a variety of tissues very early after infection, CHIKV RNA persisted specifically in joint-associated tissues for at least 16 weeks. Inoculation of Rag1(-/-) mice, which lack T and B cells, resulted in higher viral levels in a variety of tissues, suggesting that adaptive immunity controls the tissue specificity and persistence of CHIKV infection. The presence of CHIKV RNA in tissues of wild-type and Rag1(-/-) mice was associated with histopathological evidence of synovitis, arthritis, and tendonitis; thus, CHIKV-induced persistent arthritis is not mediated primarily by adaptive immune responses. Finally, we show that prophylactic administration of CHIKV-specific monoclonal antibodies prevented the establishment of CHIKV persistence, whereas therapeutic administration had tissue-specific efficacy. These findings suggest that chronic musculoskeletal tissue pathology is caused by persistent CHIKV infection and controlled by adaptive immune responses. Our results have significant implications for the development of strategies to mitigate the disease burden associated with CHIKV infection in humans.
Figures
Similar articles
-
Chikungunya Virus Evades Antiviral CD8+ T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues.J Virol. 2020 Apr 16;94(9):e02036-19. doi: 10.1128/JVI.02036-19. Print 2020 Apr 16. J Virol. 2020. PMID: 32102875 Free PMC article.
-
Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.PLoS Negl Trop Dis. 2012;6(3):e1446. doi: 10.1371/journal.pntd.0001446. Epub 2012 Mar 27. PLoS Negl Trop Dis. 2012. PMID: 22479654 Free PMC article. Review.
-
A high-dose inoculum size results in persistent viral infection and arthritis in mice infected with chikungunya virus.PLoS Negl Trop Dis. 2022 Jan 31;16(1):e0010149. doi: 10.1371/journal.pntd.0010149. eCollection 2022 Jan. PLoS Negl Trop Dis. 2022. PMID: 35100271 Free PMC article.
-
Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.J Virol. 2014 Aug;88(15):8213-26. doi: 10.1128/JVI.01032-14. Epub 2014 May 14. J Virol. 2014. PMID: 24829346 Free PMC article.
-
Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.Viral Immunol. 2017 Dec;30(10):691-702. doi: 10.1089/vim.2017.0052. Epub 2017 Sep 14. Viral Immunol. 2017. PMID: 28910194 Review.
Cited by
-
Chikungunya and Mayaro Viruses Induce Chronic Skeletal Muscle Atrophy Triggered by Pro-Inflammatory and Oxidative Response.Int J Mol Sci. 2024 Aug 16;25(16):8909. doi: 10.3390/ijms25168909. Int J Mol Sci. 2024. PMID: 39201595 Free PMC article.
-
Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.J Virol. 2015 Aug;89(15):7955-69. doi: 10.1128/JVI.00909-15. Epub 2015 May 20. J Virol. 2015. PMID: 25995257 Free PMC article.
-
Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.J Virol. 2019 Dec 12;94(1):e00841-19. doi: 10.1128/JVI.00841-19. Print 2019 Dec 12. J Virol. 2019. PMID: 31619554 Free PMC article.
-
Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity.Front Immunol. 2020 Feb 21;11:287. doi: 10.3389/fimmu.2020.00287. eCollection 2020. Front Immunol. 2020. PMID: 32153590 Free PMC article. Review.
-
Chikungunya fever: a threat to global public health.Pathog Glob Health. 2018 Jun;112(4):182-194. doi: 10.1080/20477724.2018.1478777. Epub 2018 May 28. Pathog Glob Health. 2018. PMID: 29806537 Free PMC article. Review.
References
-
- Suhrbier A, Jaffar-Bandjee MC, Gasque P. 2012. Arthritogenic alphaviruses—an overview. Nat. Rev. Rheumatol. 8:420–429 - PubMed
-
- Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. 2012. Chikungunya: a re-emerging virus. Lancet 379:662–671 - PubMed
-
- Powers AM, Logue CH. 2007. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen. Virol. 88:2363–2377 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
